International
The Morning Science

What science found today

‹
 

Topic

Pembrolizumab

3 stories about Pembrolizumab that passed the news check, newest first.

  1. Research ·

    Enfortumab Vedotin and Pembrolizumab for Cisplatin-Eligible Bladder Cancer

    A New England Journal of Medicine correspondence titled 'Enfortumab Vedotin and Pembrolizumab for Cisplatin-Eligible Bladder Cancer' was published.

    nejm.org

  2. Research ·

    Can Adjuvant Pembrolizumab Improve Outcomes in Triple-Negative Breast Cancer?

    MedPage Today published a video preview by Rena Callahan, MD, of UCLA Health Santa Clarita Cancer Care, on the phase III SWOG-S1418/NRG Oncology BR006 trial.

    MedPageToday.com - medical news for physicians

  3. Research ·

    Final trial results show promising long-term survival with lenvatinib plus pembrolizumab in advanced thymic tumors

    Final results from the phase 2 PECATI clinical trial were reported.

    Medical Xpress - latest medical and health news stories